Pregnancy associated plasma protein A: An indicator of adverse obstetric outcomes in a South India population
- 6 April 2020
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 17 (1) , 40-45
Abstract
First trimester aneuploidy screening (FTAS) has become an integral part of antenatal care in most of centers in India. The serum markers used for FTAS are pregnancy-associated plasma protein A (PAPP-A) and beta human chorionic gonadotropin. In the present study, we aimed to assess the role of PAPP-A in specific adverse fetal maternal events. To analyze pregnancy outcomes with low maternal PAPP-A (≤5th percentile) at the FTAS screening test in southern India, and them compared with a control group of >5th percentile value. A total of 1800 consecutive pregnancies in the first trimester were followed up with PAPP-A levels. The study group consisted 108 subjects, which was compared with a matched control group of 288 subjects. The outcomes considered were spontaneous abortions, fetal anomalies, preterm delivery (PTD), hypertension in pregnancy, intrauterine growth restriction, gestational diabetes, mode of delivery, and birthweight. For our grouped data, the 5th percentile value for PAPP-A was 0.49 multiple of medians, (incidence-6%). The incidence of fetal major anomalies was higher in the study group [odds ratio (OR): 1.87]. The incidence of minor anomalies, gestational diabetes, and hypertensive disorders was higher in the study group but not statistically significant. The total rate of PTDs (OR:2.1), small-for-gestation-age fetuses (OR:2.3), and low birthweight babies (OR- 2.12) was significantly higher in the study group. We found positive likelihood ratio of 1.4 for PTD, 2 for <5th percentile birthweight, and 1.7 for <10th centile birthweight. Low PAPP-A pregnancies are at risk of various obstetric complications. Hence, such a pregnancy should have closer surveillance. Further research work on intervention strategy is needed.Keywords
This publication has 20 references indexed in Scilit:
- Association of serum PAPP‐A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta‐analysisPrenatal Diagnosis, 2017
- The risk of adverse pregnancy outcome among pregnancies with extremely low maternal PAPP-APrenatal Diagnosis, 2016
- Adverse pregnancy outcome in patients with low pregnancy‐associated plasma protein‐A: The Indian ExperienceJournal of Obstetrics and Gynaecology Research, 2015
- Low pregnancy-associated plasma protein A level in the first trimester.2014
- The predictive value of 18 and 22 week uterine artery Doppler in patients with low first trimester maternal serum PAPP‐APrenatal Diagnosis, 2009
- RETIRED: Obstetrical Complications Associated With Abnormal Maternal Serum Markers AnalytesJournal of Obstetrics and Gynaecology Canada, 2008
- The efficacy of first-trimester PAPP-A and free βhCG levels for predicting adverse pregnancy outcomeJournal of Perinatal Medicine, 2006
- Association between first trimester maternal serum pregnancy associated plasma protein‐A and adverse pregnancy outcomeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2003
- Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcomePrenatal Diagnosis, 2002
- Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspectsBratislava Medical Journal, 2002